S
Samik Banerjee
Researcher at Albany Medical College
Publications - 92
Citations - 2434
Samik Banerjee is an academic researcher from Albany Medical College. The author has contributed to research in topics: Arthroplasty & Blood management. The author has an hindex of 24, co-authored 88 publications receiving 1816 citations. Previous affiliations of Samik Banerjee include Epsom and St Helier University Hospitals NHS Trust & Thomas Jefferson University Hospital.
Papers
More filters
Journal ArticleDOI
Mechanical, Anatomical, and Kinematic Axis in TKA: Concepts and Practical Applications
Jeffrey J. Cherian,Bhaveen H. Kapadia,Samik Banerjee,Julio J. Jauregui,Kimona Issa,Michael A. Mont +5 more
TL;DR: This report has reviewed and analyzed recent reports concerning mechanical, anatomic, and kinematic axis/alignment schemes used in total knee arthroplasty.
Journal ArticleDOI
Short bone-conserving stems in cementless hip arthroplasty.
TL;DR: Only a weak recommendation can be provided for clinical usage of certain stem designs, while some other designs cannot be recommended at this time because of the low quality of currently available evidence.
Journal ArticleDOI
What Host Factors Affect Aseptic Loosening After THA and TKA
TL;DR: Patients undergoing a lower-extremity total joint arthroplasty who engage in impact sports should be counseled regarding their potential increased risk of aseptic loosening; however, given the weak evidence available, it is believed that higher-level studies are necessary to clearly define the risk factors, particularly with newer-generation constructs.
Journal ArticleDOI
Systematic review comparing static and articulating spacers used for revision of infected total knee arthroplasty.
TL;DR: There was no difference in the re-infection rates, complication rates, or re-operation rates between the two groups, and currently no specific recommendation can be made about the superiority of one type of spacer over the other.
Journal ArticleDOI
High-Dose Corticosteroid Use and Risk of Hip Osteonecrosis: Meta-Analysis and Systematic Literature Review.
TL;DR: Clinicians must be wary of osteonecrosis in patients on high corticosteroid regimens, particularly in systematic lupus erythematosus patients, particularly during treatment durations of more than three months.